New Frontier in Cold Chain Logistics: Surge in Cryogenic Transport Demand, China Leads Asia-Pacific Growth

Industry Dynamics and Policy Regulations

• Market Size and Growth

The global biospecimen logistics market is projected to reach $14.5 billion by 2025, with a compound annual growth rate (CAGR) of 17.2%. The Asia-Pacific region is the fastest-growing market (20.5% growth in 2024), driven primarily by China and India. Clinical diagnostic samples account for the largest share of the market (40%), while the demand for cryogenic transportation (e.g., at -80℃) is growing at an impressive 18%, reflecting a surge in the transportation of high-value biological products.

• Policy and Standard Upgrades

China has released the national standard GB/T 45743-2025 "General Requirements for Transportation of Biological Samples and Cells," which for the first time unifies technical specifications for temperature control, packaging, and documentation. This standard, based on ISO international standards and optimized for local needs, addresses a critical gap in domestic regulations. Key improvements include clear requirements for transport container sealing tests and emergency procedures, which are crucial for promoting industry standardization.

• Corporate Strategy and Integration

International giants are accelerating their presence in the market. DHL completed its acquisition of CRYOPDP, strengthening its specialized capabilities in clinical trial cold chain logistics. In China, domestic players like SF Express Bioscience and JD Logistics are rapidly emerging, with market shares reaching $1.8 billion and $1.2 billion respectively in 2024, boasting a CAGR of over 25%. The top five companies (CR5) hold a combined market share of 60%. However, new entrants, such as Rapidio in India, are increasing competition and leading to a more fragmented market.

Upcoming Industry Exhibitions and Academic Events

• International Exhibitions

BIOCHINA2025 (The 10th EBC Bio-Industry Conference)
Held in Suzhou in March 2025, the event featured YuanNeng Bio's BSE-PRO cryogenic storage system, which uses a dual liquid/electric cooling mode to achieve low energy consumption and quiet operation, reducing overall operational costs by over 40%.

• Guangzhou International Cold Chain Exhibition

Scheduled for August 22-24, 2025, at the Canton Fair Complex, this exhibition will focus on end-to-end cold chain solutions. It will also host the Cross-border Cold Chain Summit, attracting buyers from Southeast Asian countries like Thailand and Malaysia.

• Specialized Academic Conferences

Academic Annual Meeting of the Biobank and Clinical Big Data Integration Branch
This conference will be held in Nanjing on August 23, 2025. It will showcase HuaChuan Technology's Phoenix series of automated storage systems, which supports the retrieval of entire boxes or individual tubes of deep-frozen samples.

• China International Gene and Cell Therapy Summit (CGCT)

Expected to take place in Shanghai in August 2025, this summit will focus on temperature-controlled validation and international logistics collaboration for the transportation of gene therapy drugs.

As the industry matures, the convergence of technological innovation, regulatory oversight, and strategic business consolidation will be key. Looking ahead, the focus for stakeholders will likely shift toward leveraging digital platforms to enhance traceability and compliance, while forging international partnerships to navigate the complexities of cross-border biologistics. The coming years are poised to be a period of significant transformation, solidifying the bio-sample logistics sector as a critical and indispensable part of the global life sciences ecosystem.